Description of the medicine: Volekam (Volecamum)
A solution of 6% hydroxyethyl starch with a molecular weight of 170,000 + 30,000 in an isotonic sodium chloride solution.
Clear, colorless liquid; pH 5, 0 - 7, 0.
Volek is a colloid osmotic plasma-replacing drug with hemodynamic effects. Effective in conditions accompanied by hypovolemic syndrome (with traumatic shock, burns, blood loss, etc.).
Enter the wolves jet or drip through a system with a filter for blood transfusion. Given the individual sensitivity of the patient to various transfusion environments, the infusion begins drip. After the introduction of the first 5 - 10 and the next 30 drops, it is necessary to take a break for 3 minutes to determine the patient's tolerance to the drug.
With the developed shock, accompanied by blood loss, the wolves are injected intravenously in a dose of up to 500 ml.
If necessary, the dose of the drug can be increased to 1500 ml.
The use of volekam does not exclude the need for other anti-shock measures (analgesia, the use of cardiac, vasotonic and other symptomatic agents).
During operations, in order to prevent operative shock, intravenous administration of Volecame in a dose of 400 - 600 ml should be carried out drip with the transition to jet in the event of a drop in blood pressure.
In the postoperative period, wolves are injected jet or drip, respectively, blood loss.
The total dose of volekama in the preoperative and postoperative periods is determined by hemodynamic parameters and the general condition of patients and is 1500 ml per day.
The drug can be used simultaneously with other traditional transfusion agents (polyglucin, hemodesis, etc.).
When using wolekam, allergic reactions are possible (urticaria, skin itching, Quincke's edema, etc.), increased heart rate, lowering blood pressure, fever, headache, nausea, and vomiting. In these cases, the injection of volekam should be discontinued and symptomatic treatment given.
The use of volekam is contraindicated in case of a skull injury accompanied by an increase in intracranial pressure, as well as in other cases when intravenous fluids are contraindicated in high doses, in particular with high blood pressure, congestive heart failure, impaired renal function, accompanied by oligo or anuria.
Release form: in glass bottles on 100; 200 and 400 ml.
Storage: at a temperature of + 10 to + 25 'C. Freezing is not allowed.